Home > News > Immunicon Announces Agreements with R&D Systems
August 19th, 2003
Immunicon Announces Agreements with R&D Systems
Abstract:
Immunicon Corporation today announced the completion of a non-exclusive license and supply agreement with R&D Systems, Inc. of Minneapolis, MN. In addition, under the terms of a separate agreement, R&D Systems, a wholly-owned subsidiary of Techne Corporation made an equity investment in Immunicon. Under the license and supply agreement, R&D Systems will use Immunicon's magnetic nano-particle cell isolation technology in conjunction with their reagents to develop products for life science research. (PDF)
Source:
PRNewswire
Related News Press |
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |